AIRR Long-term Perspectives "Characterization of neonatal chronic lung disease in former premature infants at the age of 2 and 5 years

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00012429

Enrollment

500

Registered

2017-05-26

Start date

2017-06-01

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

P27.1

Interventions

Group 1: 2 and 5 years follow-up in former VLBW Infants (< 32 weeks gestational age and/or 1500g birth weight) with BPD: 1) ILFT at 2 and 5 years of age 2) echocardiography 3) biosampling (blood, ur

Eligibility

Sex/Gender

All

Age

1 Days to No maximum

Inclusion criteria

Inclusion criteria: Preterm infants with or without later development of BPD and a gestational age (GA) = 32 weeks from the AIRR study (DRKS 00004600) with BPD (Arm 1) and without BPD (Arm 2).

Exclusion criteria

Exclusion criteria: Exclusion criteria were severe congenital malformations (e.g. hypoplastic left-heart syndrome, severe hypoplasia of the lungs or congenital diaphragmatic hernia), chromosomal abnormalities (e.g. trisomy 13 or 18) , inborn errors of metabolism, and decision for palliative therapy directly after birth.

Design outcomes

Primary

Measure	Time frame
Course of BPD at the age of 2 and 5 years, Investigation by means of MRI, ILFT and Proteomics	—

Secondary

Measure	Time frame
Neurological impairment at 2 and 5 years of age	—

Countries

Germany

Contacts

Public ContactKai Förster

Klinikum der Universität München, Campus Großhadern

Kai.Foerster@med.uni-muenchen.de089-440072801

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026